Blockade of Common Gamma Chain Cytokine Signaling With REGN7257, an Interleukin 2 Receptor Gamma (IL2RG) Monoclonal Antibody

Time: 2:40 pm
day: Conference Day One


  • Blockade of cytokine signalling protected mice against immune cell-mediated pathology in multiple disease models
  • Providing evidence of γc cytokines as key drivers of pathogenic immune cell responses
  • Offering a potentially novel strategy for the management of inflammatory and autoimmune diseases, such as GVHD, immune aplastic anemia and MS